Navigation Links
Multicolor Laser Photocoagulator MC-300

ProductsMulticolor Laser Photocoagulator MC-300
Company NIDEK, Inc.
Item Multicolor Laser Photocoagulator MC-300
Features 
  • High Power Multicolor (Red, Yellow & Green) Diode-Pumped Solid State Laser
  • Same Wavelength Aiming & Coagulation Beams
  • Advanced SOLIC Optical Design for Safe Corneal Transmission of Laser Treatments
  • Standard Dual Delivery
  • Available Slit Lamp Delivery Systems for NIDEK, ZEISS and Haag Streit
  • Moving Safety Filter allows for Better Laser Burn Intensities.
  • Small Footprint and Reduced Input Power Consumption
Description NIDEK MC-300 is designed to treat a diverse range of patients suffering from such conditions as age-related macular degeneration, glaucoma, diabetic retinopathy and retinal diseases to meet all the clinical needs of retinal specialists.
Info NIDEK, Inc.
Customer Service: 1-800-223-9044
Web site: http://www.usa.nidek.com

Related medicine products :

1. Coaxial Multicolor LIO
2. Full Handle Laseredge Stab Blade Knife, 15 blade
3. Full Handle Laseredge Stab Blade Knife, 15 blade, 3 mm
4. Full Handle Laseredge Stab Blade Knife, 22.5 blade
5. Full Handle Laseredge Stab Blade Knife, 45 blade
6. Full Handle Laseredge Stab Blade Knife, 30 blade
7. Full Handle Laseredge Crescent Blade Knife, angled bevel up
8. Full Handle Laseredge Crescent Blade Knife, straight
9. Full Handle Laseredge Crescent Blade Knife, angled double bevel
10. Full Handle Laseredge Crescent Blade Knife, angled bevel down
11. Full Handle Laseredge Implant Blade Knife, 4.0 mm straight
Breaking Medicine News(10 mins):Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3Health News:Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients 2
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3